Non-Small Cell Lung Cancer — 5-Minute Journal Club Issue 1 with Dr Jacob Sands: Defining the Role of TROP2-Directed Antibody-Drug Conjugates
- Author
- Dr. Neil Love
- Published
- Fri 15 Aug 2025
- Episode Link
- https://oncologytoday.captivate.fm/episode/5547-5mjc2025-trop2lung-1
Dr Jacob Sands from Dana-Farber Cancer Institute in Boston, Massachusetts, discusses recent developments with TROP2-directed antibody-drug conjugates in the management of non-small cell lung cancer.
CME information and select publications here.
